Alyssum Therapeutics logo

Alyssum Therapeutics Funding & Investors

Cambridge, MA

Alyssum Therapeutics, a biotechnology company which is developing next-generation immunotherapies to modulate B cells

alyssumtx.com

Total Amount Raised: $26,000,000

Alyssum Therapeutics' Investors

Alyssum Therapeutics Funding Rounds

  • Series A

    $26,000,000

    Series A Investors

    Patrick Soon-Shiong
    Famy Care
    Accel
    Navam Capital
Funding info provided by Diffbot.